Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Healthcare Cannabis
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Core One Labs Inc
Bullboard Posts
User Avatar Image
(1)
•••
Comment by Straniuson Jul 27, 2017 8:12pm
122 Views
Post# 26519433

RE:RE:So... I called Azonic

RE:RE:So... I called AzonicI have ZERO concern about LDS finding a viable LEGAL distributor to get its products to market in the medium-term. There is a LEGAL market (at a State level) for medical cannabis cultivation/transportation/distribution in California currently and in less than 6 months there will be a LEGAL market (at a State level) for recreational cannabis cultivation/transportation/distribution.

Some party will step in to fill this void (if one does not currently exist). My concern is with the lack of detail provided up to this point by management and the impact to management credibility the longer they take to clarify their transportation/distribution plans.

So with that said, I believe you made a mistake to sell LDS because there is no path to get their product to market. Does this mean the price won't go lower? No it does not. But can and will LDS find a LEGAL way to move their product to market? Undoubtedly YES.

~S

Loudermilk wrote: I assure you that Azonic Health Sciences contact is : clay@spraylabs.com under Thomas Kahler. I got this from government documents issued from AAA Corporate Services. It has an air of mystery, which for entertainment I love, when it comes to investing, I run for the hills.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities